WBO:MDG1 (Germany)  
Medigene AG logo

Medigene AG

€ 2.04 (+2%) Oct 6
P/E:
At Loss
P/B:
0.74
Market Cap:
€ 48.39M ($ 47.46M)
Enterprise V:
€ 23.49M ($ 23.04M)
Volume:
-
Avg Vol (2M):
3.68K
Also Trade In:
Volume:
-
Market Cap €:
48.39M
Market Cap $:
47.46M
PE Ratio:
At Loss
Avg Vol (2-Month):
3.68K
Enterprise Value €:
23.49M
Enterprise Value $:
23.04M
PB Ratio:
0.74
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Medigene AG is a Germany based biotechnology company. Along with its subsidiaries, the company is primarily engaged in developing immunotherapies to target various forms and stages of cancer with candidates in clinical and pre-clinical development. The group is focused on the development of personalized T cell-based therapies. The operating segments of the organization are Immunotherapies and Other products. Immunotherapies consist of T-cell receptor-based adoptive T-cell therapy, DC vaccines, and T-cell-specific monoclonal antibodies. The group operates in the United States, Europe, and Other countries, of which majority of the revenue is derived from operations in the United States.

Financials

WBO:MDG1's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 31.456
EPS (TTM) (€) -0.1
Beta 0.14
Volatility % 62.05
14-Day RSI 41.03
14-Day ATR (€) 0.059931
20-Day SMA (€) 2.1435
12-1 Month Momentum % -33.8
52-Week Range (€) 1.895 - 4.455
Shares Outstanding (Mil) 24.56

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Medigene AG Filings

Document Form Filing Date
No Filing Data

Medigene AG Analysis

Share your research